Evan Myrianthopoulos
CIK 1050955 · View on SEC EDGAR ↗
First SEC filing: Sept. 27, 2010 · Latest: Sept. 27, 2010
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 29, 2007 | SNGX | P | 70,000 | $0.31 | $21,700 | 224,780 Direct | +45.23% | Acquired | -100.0% (price as of 2026-08-18) |
| Feb. 9, 2007 | SNGX | P | 53,191 | $0.47 | $25,000 | 154,817 Direct | +52.34% | Acquired | -100.0% (price as of 2026-08-18) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Dec. 1, 2011 | SNGX | Stock Option (Right to Buy) [F1] | Common Stock (1,200,000) | $0.03 | Nov. 30, 2021 | 1,200,000 | Acquired |
| Sept. 23, 2010 | SNGX | Stock Option (Right to Buy) [F1] | Common Stock (1,050,000) | $0.23 | June 30, 2020 | 1,050,000 | Acquired |
| Dec. 18, 2008 | SNGX | Stock Options (Right to Buy) [F1] | Common Stock [F1] | — | Dec. 17, 2018 | 1,200,000 | Acquired |
| Aug. 10, 2007 | SNGX | Stock Options (Right to Buy) [F1] | Common Stock [F1] | — | Aug. 9, 2017 | 550,000 | Acquired |
| May 10, 2006 | SNGX | Stock Options (right to buy) [F2] | Common Stock (400,000) | $0.35 | May 10, 2016 | 400,000 | Acquired |
| April 10, 2006 | SNGX | Stock Warrants (right to buy) | Common Stock (90,220) | $0.45 | April 10, 2016 | 90,220 | Acquired |
| Dec. 13, 2004 | SNGX | Stock Options (right to buy) | Common Stock (500,000) | $0.49 | Dec. 13, 2014 | 500,000 | Acquired |
| Nov. 10, 2004 | SNGX | Stock Options (right to buy) | Common Stock (150,000) | $0.47 | Nov. 10, 2014 | 150,000 | Acquired |
| Sept. 9, 2004 | SNGX | Stock Options (right to buy) | Common Stock (50,000) | $0.58 | Sept. 9, 2014 | 50,000 | Acquired |
| Sept. 9, 2004 | SNGX | Stock Options (right to buy) | Common Stock (50,000) | $0.58 | Sept. 9, 2014 | 50,000 | Acquired |
| Sept. 15, 2003 | SNGX | — | Common Stock (50,000) | $0.90 | Sept. 15, 2013 | 50,000 | Acquired |
| Sept. 15, 2003 | SNGX | Stock Warrants | Common Stock | $0.88 | Sept. 15, 2008 | 77,694 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2009 | $202,605 | $70,000 | — | — | — | — | $24,811 | $297,416 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.